CervoMed (CRVO) vs eXoZymes (EXOZ)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
eXoZymes (EXOZ) has outperformed CervoMed (CRVO) over the past year, losing 59.7% versus a loss of 63.1%. CervoMed is the larger company by market cap ($49.6 million vs $49.0 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CRVO | EXOZ |
|---|---|---|
| Share price | $3.28 | $5.27 |
| Market cap | $49.59M | $49.04M |
| 1-day change | +3.14% | -4.87% |
| YTD return | -58.48% | -51.65% |
| 1-year return | -63.15% | -59.68% |
| 5-year return | -90.89% | — |
| EPS (TTM) | $-3.21 | $-1.19 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.00 | $18.40 |
| 52-week low | $2.13 | $4.35 |
| Distance from 52-week high | -67.20% | -71.36% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +369.51% | — |
| Average volume | 339.08K | 6.97K |
| Shares outstanding | 15.12M | 9.30M |
| Employees | 15 | 32 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About CervoMed
CRVO stock →CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule drug that crosses the bloodbrain barrier and inhibits the enzyme p38a.
Healthcare · Biotechnology · 15 employees
About eXoZymes
EXOZ stock →eXoZymes, Inc. operates as a development stage biotechnology company.
Healthcare · Biotechnology · 32 employees
CRVO vs EXOZ FAQ
Which is bigger, CervoMed or eXoZymes?
CervoMed (CRVO) is larger, with a market capitalization of $49.59M compared with $49.04M for eXoZymes (EXOZ).
Which stock has performed better over the past year, CRVO or EXOZ?
EXOZ returned -59.68% over the past 12 months, compared with -63.15% for CRVO (price return, excluding dividends). Past performance does not predict future results.
Are CervoMed and eXoZymes in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.